Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01655329 · ClinicalTrials.gov registry record

Reader Study to Demonstrate That Use of ClearRead Confirm is Superior to the Use Standard AP/PA X-ray Image

A clinical trial, sponsored by Georgetown University.

Completed
Registry status
10
Enrollment target

NCT01655329 is a clinical trial that has completed, run by Georgetown University. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01655329 has completed, sponsored by Georgetown University.

COMPLETED
Registry status
10 participants
Enrollment target

Study Summary

This is a study to determine whether or not a new type of software is, or is not, of benefit. The software, ClearRead Confirm, is designed to enhance the ability of radiologists to detect tubes, lines and wires that may be placed within a patients chest. These types of devices are commonly used for very sick patients in intensive care units and are also used following surgery and in the treatment of cancer. This study will test radiologist's detection of the tips of these devices comparing the results with standard chest radiographs and the the modified chest radiographs. The primary interest is in the time used to interpret the radiograph. We will determine if there is any change in accuracy of detection.

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2012-08
Est. Completion 2013-02

Sponsor

Georgetown University

227 total trials

What the Registry Record Tells You About NCT01655329

The ClinicalTrials.gov registry entry for NCT01655329 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01655329 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01655329 about?

NCT01655329 is a clinical study titled "Reader Study to Demonstrate That Use of ClearRead Confirm is Superior to the Use Standard AP/PA X-ray Image". This is a study to determine whether or not a new type of software is, or is not, of benefit. The software, ClearRead Confirm, is designed to enhance the ability of radiologists to detect tubes, lines and wires that may be placed within a patients chest. These types of devices are commonly used for ...

What is the current status of trial NCT01655329?

This trial is currently completed. The enrollment target is 10 participants. The study started on 2012-08. Estimated completion is 2013-02.

Who is sponsoring clinical trial NCT01655329?

This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.